Supplementary Figure 7 from Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways

Autor:	Mohamed El-Tanani, Philip S. Rudland, Patrick G. Johnston, Dean A. Fennell, Pasi Janne, Ken O'Byrne, Osama Sharaf Eldin, Angela Platt-Higgins, James T. Murray, Claire Grills, Ka-Kui Chan, Hiu-Fung Yuen
Rok vydání:	2023
Popis:	PDF file - 3.6K, Cancer cells with K-Ras activation mutation (HCT116/Hkh-2 isogenic pair) are more susceptible to Ran silencing-induced apoptosis.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05d29ff835d261255b4ca4e840b09a77 https://doi.org/10.1158/1078-0432.22445180.v1 Zobrazit plný text záznamu